Zyla Life Sciences Operating Lease Right-of-Use Assets
Zyla Life Sciences had Operating Lease Right-of-Use Assets of $2.48 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2020-05-14
- 2020-03-31: Operating Lease, Right-of-Use Asset $2.48M.
- 2019-12-31: Operating Lease, Right-of-Use Asset $2.67M.
- 2019-09-30: Operating Lease, Right-of-Use Asset $2.88M.
- 2019-06-30: Operating Lease, Right-of-Use Asset $1.58M.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2020-03-31 | $2.48M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $2.67M 10-Q · filed 2020-05-14 |
| 2019-09-30 | $2.88M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.58M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $1.75M 10-Q · filed 2019-05-17 |
| 2019-02-01 | $1.85M 10-Q · filed 2020-05-14 |
| 2019-01-31 | $1.85M 10-Q · filed 2020-05-14 |